Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance

Clinical Hemorheology and Microcirculation

Volumn 37, Issue 4, 2007, Pages 309-318

  Sola E ^a   Vaya A ^b   Simo M ^b   Hernandez Mijares A ^a   Morillas, C ^a   Espana F ^b   Estelles A ^b   Corella, D ^c  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Blood viscosity; Hemorheology; Obesity; Plasma viscosity

Indexed keywords

CHOLESTEROL; FIBRINOGEN; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BASAL METABOLIC RATE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMATOCRIT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; PLASMA VISCOSITY; RISK FACTOR; SEX RATIO; WEIGHT REDUCTION;

ADULT; BLOOD VISCOSITY; BODY MASS INDEX; CALORIC RESTRICTION; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 35048854028     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. C. Le Devehat, M. Vimeux and T. Khodabandehlou, Blood rheology in patients with diabetes mellitus, Clin. Hemorheol. Microcirc. 30 (2004), 297-300.
2. P. Fanari, R. Somazzi, F. Nasrawi et al., Haemorheological changes in obese adolescents after short-term diet, Int. J. Obes. Relat. Metab. Disord. 17 (1993), 487-494.
3. E. Rillaerts, L. van Gaal, D.Z. Xiang, G. Vansant and I. De Leeuw, Blood viscosity in human obesity: relation to glucose tolerance and insulin status, Int. J. Obes. 13 (1989), 739-745.
4. G. Avellone, V. Di Garbo, R. Cordova et al., Evaluation of cardiovascular risk factors in overweight and obese subjects, Int. Angiol. 13 (1994), 25-29.
5. K. Landin, L. Stigendal, E. Eriksson et al., Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1, Metabolism 39 (1990), 1044-1048.
6. G. Avellone, V. Di Garbo, R. Cordova, G. Raneli, R. De Simone and G. Bompiani Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution, Thromb. Res. 75 (1994), 223-231.
7. M. Poggi, G. Palareti, R. Biagi et al., Prolonged very low calorie diet in highly obese subjects reduces plasma viscosity and red cell aggregation but not fibrinogen, Int. J. Obes. Relat. Metab. Disord. 18 (1994), 490-496.
8. A. Craveri, G. Tornaghi, L. Panagardi et al., Hemorheological changes in obesity, Clinical Hemorheology 8 (1988), 723-736.
9. I. Haszon, F. Papp, J. Kovacs et al., Platelet aggregation, blood viscosity and serum lipids in hypertensive and obese children, Eur. J. Pediatr. 162 (2003), 385-390.
10. E. Cacciari, A. Balsamo, G. Palareti et al., Haemorheologic and fibrinolytic evaluation in obese children and adolescents, Eur. J. Pediatr. 147 (1988), 381-384.
11. A. Craveri, G. Tornaghi, L. Panagardi et al., Hemorheological changes in obese children and the effect of weight loss, Clinical Hemorheology (1992), 573-578.
12. A. Craveri, G. Tornaghi, L. Panagardi, R. Ranieri and L. Giavardi, Weight loss does not affect the hemorheological and fibrinolytic changes in obesity, Clinical Hemorheology 10 (1990), 541-546.
13. J.F. Brun, I. Aloulou and E. Varlet-Marie, Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?, Clin. Hemorheol. Microcirc. 30 (2004), 203-209.
14. S.B. Solerte, M. Fioravanti, N. Pezza et al., Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk, Int. J. Obes. Relat. Metab. Disord. 21 (1997), 417-423.
15. M. Wysocki, M. Krotkiewski, M. Braide and U. Bagge, Hemorheological disturbances, metabolic parameters and blood pressure in different types of obesity, Atherosclerosis 88 (1991), 21-28.
16. C.R. Hankey, A. Rumley, G.D. Lowe, M. Woodward and M.E. Lean, Moderate weight reduction improves red cell aggregation and factor VII activity in overweight subjects, Int. J. Obes. Relat. Metab. Disord. 21 (1997), 644-650.
17. S. Carroll, C.B. Cooke and R.J. Butterly, Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness, Blood Coagul. Fibrinolysis 11 (2000), 71-78.
18. A. Perez-Martin, M. Dumortier, E. Pierrisnard, E. Raynaud, J. Mercier and J.F. Brun, Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance? Clin. Hemorheol. Microcirc. 25 (2001), 91-103.
19. S. Kobayashi, T. Hamazaki, K. Onishi and F. Nomura, Blood viscosity in fatty liver patients with obesity, Clin. Hemorheol. 6 (1986), 629-633.
20. G.A. Rosito, R.B. D'Agostino, J. Massaro et al., Association between obesity and a prothrombotic state: the Framingham Offspring Study, Thromb. Haemost. 91 (2004), 683-689.
21. F. Jung, H.G. Roggenkamp, R. Schneider and H. Kiesewetter, [The capillary tube plasma viscosimeter. A new apparatus for measuring plasma viscosity], Biomed. Tech. (Berl.) 28 (1983), 249-252.
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher and R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia 28 (1985), 412-419.
23. A.R. Folsom, H.T. Qamhieh, R.R. Wing et al., Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults, Arterioscler. Thromb. 13 (1993), 162-169.
24. M. Abdollahi, M. Cushman and F.R. Rosendaal, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use, Thromb. Haemost. 89 (2003), 493-498.
25. H.H. Ditschuneit, M. Flechtner-Mors and G. Adler, Fibrinogen in obesity before and after weight reduction, Obes. Res. 3 (1995), 43-48.
26. G. Imperatore, G. Riccardi, C. Iovine, A.A. Rivellese and O. Vaccaro, Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study, Diabetes Care 21 (1998), 649-654.
27. W. Koenig, M. Sund, B. Filipiak, A. Doring, H. Lowel and E. Ernst, Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992, Arterioscler. Thromb. Vasc. Biol. 18 (1998), 768-772.
28. M. Cigolini, G. Targher, I.A. Bergamo Andreis, M. Tonoli, G. Agostino and G. De Sandre, Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men, Arterioscler. Thromb. Vasc. Biol. 16 (1996), 368-374.
29. I. Juhan-Vague, S.G. Thompson and J. Jespersen, Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group, Arterioscler. Thromb. 13 (1993), 1865-1873.
30. I. Mertens and L.F. Van Gaal, Visceral fat as a determinant of fibrinolysis and hemostasis, Semin. Vasc. Med. 5 (2005), 48-55.
31. L.R. Pickart and M.M. Thaler, Fatty acids, fibrinogen and blood flow: a general mechanism for hyperfibrinogenemia and its pathologic consequences, Med. Hypotheses 6 (1980), 545-557.
32. C. Peyreigne, D. Bouix, A. Aissa Benhaddad et al., Hemorheologic effects of a short-term ketogenetic diet, Clin. Hemorheol. Microcirc. 21 (1999), 147-153.
33. O.L. Svendsen, C. Hassager, C. Christiansen, J.D. Nielsen and K. Winther, Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women, Arterioscler. Thromb. Vasc. Biol. 16 (1996), 381-385.
34. I. Mertens and L.F. Van Gaal, Obesity, haemostasis and the fibrinolytic system, Obes. Rev. 3 (2002), 85-101.
35. J.N. Primrose, J.A. Davies, C.R. Prentice, R. Hughes and D. Johnston, Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity, Thromb. Haemost. 68 (1992), 396-399.
36. P. Marckmann, S. Toubro and A. Astrup, Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects, Eur. J. Clin. Nutr. 52 (1998), 329-333.
37. M. Slabber, H.C. Barnard, J.M. Kuyl and C.J. Badenhorst, Effect of a short-term very low calorie diet on plasma lipids, fibrinogen, and factor VII in obese subjects, Clin. Biochem. 25 (1992), 334-335.
38. P. Rissanen, E. Vahtera, T. Krusius, M. Uusitupa and A. Rissanen, Weight change and blood coagulability and fibrinolysis in healthy obese women, Int. J. Obes. Relat. Metab. Disord. 25 (2001), 212-218.
39. M. Ercan, D. Konukoglu and T. Erdem Yesim, Association of plasma viscosity with cardiovascular risk factors in obesity: an old marker, a new insight, Clin. Hemorheol. Microcirc. 35 (2006), 441-446.
40. J.S. Yudkin, Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?, Diabetes Care 22(Suppl. 3) (1999), C25-30.
41. I. Aloulou, E. Varlet-Marie, J. Mercier and J.F. Brun, The hemorheological aspects of the metabolic syndrome are a combination of separate effects of insulin resistance, hyperinsulinemia and adiposity, Clin. Hemorheol. Microcirc. 35 (2006), 113-119.
42. R. Lo Presti, D. Sinagra, M. Montana, A.M. Scarpitta, A. Catania and G. Caimi, Haemorheological profile in metabolic syndrome, Clin. Hemorheol. Microcirc. 26 (2002), 241-247.
43. E. Tozzi, M.G. Tozzi-Ciancarelli, C. Di Massimo, A. Mascioli, T. Gentile and F. De Matteis, Hemorheological parameters and body weight loss in obese children, Clin. Hemorheol. 14 (1994), 203-211.
44. G. de Simone, R.B. Devereux, S. Chien, M.H. Alderman, S.A. Atlas and J.H. Laragh, Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults, Circulation 81 (1990), 107-117.
45. A. Hoieggen, E. Fossum, A. Moan, E. Enger and S.E. Kjeldsen, Whole-blood viscosity and the insulin-resistance syndrome, J. Hypertens. 16 (1998), 203-210.
46. M. Valencia-Flores, A. Orea, V.A. Castano et al., Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients, Obes. Res. 8 (2000), 262-269.
47. M. Ogren, H. Eriksson, D. Bergqvist and N.H. Sternby, Subcutaneous fat accumulation and BMI associated with risk for pulmonary embolism in patients with proximal deep vein thrombosis: a population study based on 23 796 consecutive autopsies, Intern. Med. 258 (2005), 166-171.